Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...
Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...
Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Waitlist survival at 90 days improved from 86.5% before ...
Researchers have unveiled a groundbreaking advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese Acute-on-Chronic Liver Failure Consortium (CATCH-LIFE)-MELD score). This innovative ...
Rochester, Minn.-based Mayo Clinic developed an artificial intelligence model using electrocardiogram data that outperformed the current model for end-stage liver disease score in predicting severe ...
Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver transplant, more likely to receive a transplant, and less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results